» Articles » PMID: 32274385

Human Obesity Induces Dysfunction and Early Senescence in Adipose Tissue-Derived Mesenchymal Stromal/Stem Cells

Abstract

Background: Chronic inflammatory conditions like obesity may adversely impact the biological functions underlying the regenerative potential of mesenchymal stromal/stem cells (MSC). Obesity can impair MSC function by inducing cellular senescence, a growth-arrest program that transitions cells to a pro-inflammatory state. However, the effect of obesity on adipose tissue-derived MSC in human subjects remains unclear. We tested the hypothesis that obesity induces senescence and dysfunction in human MSC.

Methods: MSC were harvested from abdominal subcutaneous fat collected from obese and age-matched non-obese subjects ( = 40) during bariatric or kidney donation surgeries, respectively. MSC were characterized, their migration and proliferation assessed, and cellular senescence evaluated by gene expression of cell-cycle arrest and senescence-associated secretory phenotype markers. studies tested MSC effect on injured human umbilical vein endothelial cells (HUVEC) function.

Results: Mean age was 59 ± 8 years, 66% were females. Obese subjects had higher body-mass index (BMI) than non-obese. MSC from obese subjects exhibited lower proliferative capacities than non-obese-MSC, suggesting decreased function, whereas their migration remained unchanged. Senescent cell burden and phenotype, manifested as , , , and gene expression, were significantly upregulated in obese subjects' MSC. BMI correlated directly with expression of , , and . Furthermore, co-incubation with non-obese, but not with obese-MSC, restored VEGF expression and tube formation that were blunted in injured HUVEC.

Conclusion: Human obesity triggers an early senescence program in adipose tissue-derived MSC. Thus, obesity-induced cellular injury may alter efficacy of this endogenous repair system and hamper the feasibility of autologous transplantation in obese individuals.

Citing Articles

3D Culture of MSCs for Clinical Application.

Gao Q, Cekuc M, Ergul Y, Pius A, Shinohara I, Murayama M Bioengineering (Basel). 2025; 11(12.

PMID: 39768017 PMC: 11726872. DOI: 10.3390/bioengineering11121199.


When do the pathological signs become evident? Study of human mesenchymal stem cells in MDPL syndrome.

Paola S, Lara G, Michela M, Silvia D, Serena M, Rosalba P Aging (Albany NY). 2024; 16(22):13505-13525.

PMID: 39611849 PMC: 11723661. DOI: 10.18632/aging.206159.


Adipose-Derived Mesenchymal Stem Cells from Arthritis Patients: Differential Modulation of CD4⁺ T Cell Activation and Cytokine Production.

Oldak M, Kurowska W, Plebanczyk M, Janicka I, Radzikowska A, Skalska U Med Sci Monit. 2024; 30:e945273.

PMID: 39543859 PMC: 11575092. DOI: 10.12659/MSM.945273.


Obesity-associated Inflammation and Alloimmunity.

Zhou H, Gizlenci M, Xiao Y, Martin F, Nakamori K, Zicari E Transplantation. 2024; .

PMID: 39192462 PMC: 11868468. DOI: 10.1097/TP.0000000000005183.


Optimizing Mesenchymal Stem Cells for Regenerative Medicine: Influence of Diabetes, Obesity, Autoimmune, and Inflammatory Conditions on Therapeutic Efficacy: A Review.

Przywara D, Petniak A, Gil-Kulik P Med Sci Monit. 2024; 30:e945331.

PMID: 39154207 PMC: 11340262. DOI: 10.12659/MSM.945331.


References
1.
Khan S, Awad E, Oszwald A, Mayr M, Yin X, Waltenberger B . Premature senescence of endothelial cells upon chronic exposure to TNFα can be prevented by N-acetyl cysteine and plumericin. Sci Rep. 2017; 7:39501. PMC: 5206708. DOI: 10.1038/srep39501. View

2.
Baker D, Wijshake T, Tchkonia T, LeBrasseur N, Childs B, van de Sluis B . Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature. 2011; 479(7372):232-6. PMC: 3468323. DOI: 10.1038/nature10600. View

3.
Kim S, Jiang K, Ogrodnik M, Chen X, Zhu X, Lohmeier H . Increased renal cellular senescence in murine high-fat diet: effect of the senolytic drug quercetin. Transl Res. 2019; 213:112-123. PMC: 6783353. DOI: 10.1016/j.trsl.2019.07.005. View

4.
Choung H, Bomback A, Stokes M, Santoriello D, Campenot E, Batal I . The spectrum of kidney biopsy findings in patients with morbid obesity. Kidney Int. 2019; 95(3):647-654. DOI: 10.1016/j.kint.2018.11.026. View

5.
Hales C, Fryar C, Carroll M, Freedman D, Ogden C . Trends in Obesity and Severe Obesity Prevalence in US Youth and Adults by Sex and Age, 2007-2008 to 2015-2016. JAMA. 2018; 319(16):1723-1725. PMC: 5876828. DOI: 10.1001/jama.2018.3060. View